Lipella Pharmaceuticals Management
Management criteria checks 2/4
Lipella Pharmaceuticals' CEO is Jon Kaufman, appointed in Jan 2005, has a tenure of 19.83 years. total yearly compensation is $323.38K, comprised of 63.1% salary and 36.9% bonuses, including company stock and options. directly owns 9.29% of the company’s shares, worth $271.90K. The average tenure of the management team and the board of directors is 17.3 years and 2.7 years respectively.
Key information
Jon Kaufman
Chief executive officer
US$323.4k
Total compensation
| CEO salary percentage | 63.1% |
| CEO tenure | 19.8yrs |
| CEO ownership | 9.3% |
| Management average tenure | 17.3yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$4m |
| Jun 30 2024 | n/a | n/a | -US$4m |
| Mar 31 2024 | n/a | n/a | -US$5m |
| Dec 31 2023 | US$323k | US$204k | -US$5m |
| Sep 30 2023 | n/a | n/a | -US$4m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | n/a | n/a | -US$3m |
| Dec 31 2022 | US$183k | US$183k | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$3m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$914k | US$183k | -US$2m |
| Dec 31 2020 | US$183k | US$183k | -US$62k |
Compensation vs Market: Jon's total compensation ($USD323.38K) is below average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Jon's compensation has increased whilst the company is unprofitable.
CEO
Jon Kaufman (58 yo)
19.8yrs
Tenure
US$323,383
Compensation
Dr. Jonathan Kaufman, also known as Jon, PhD, MBA, co-founded Lipella Pharmaceuticals Inc. in 2005 and serves as its President, Chief Executive Officer, Secretary and Treasurer and Chairman of the Board of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 19.8yrs | US$323.38k | 9.29% $ 271.9k | |
| Co-Founder | 19.8yrs | US$315.08k | 9.07% $ 265.5k | |
| Chief Financial Officer | 2yrs | US$260.00k | 0% $ 0 | |
| Director of Operations | 14.7yrs | no data | 0% $ 0 | |
| Controller | no data | no data | no data |
17.3yrs
Average Tenure
58yo
Average Age
Experienced Management: LIPO's management team is seasoned and experienced (17.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 19.8yrs | US$323.38k | 9.29% $ 271.9k | |
| Co-Founder | 16.8yrs | US$315.08k | 9.07% $ 265.5k | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | 5.74% $ 168.1k | |
| Independent Director | 3.2yrs | US$62.50k | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Independent Director | 2.7yrs | US$63.30k | 0% $ 0 | |
| Independent Director & Member of Advisory Board | 3.2yrs | US$62.50k | 0% $ 0 | |
| Chair of the Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data |
2.7yrs
Average Tenure
58yo
Average Age
Experienced Board: LIPO's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.